We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look at where YPF Sociedad Anónima (NYSE:YPF) stands against other biotech stocks that dominate Monday’s top gainers. The stock market kicked off the shortened trading week on a positive note, with Wall Street’s major indices finishing in the green following President Donald Trump’s temporary tax reprieve on technology companies. The S&P 500 recorded the highest gain, up 0.79 percent, while the Dow Jones came second at 0.78 percent. The tech-heavy Nasdaq was also up by 0.64 percent. Benchmark indices aside, 10 companies dominated by biotechnology firms mirrored the broader market optimism, recording modest gains during the session. In this article, let us explore Monday’s top 10 gainers and the reasons behind their gains. To come up with the list, we only considered the stocks with $2 billion market capitalization and $5 million trading volume. An oil platform in the North Sea, standing tall and proud against a backdrop of choppy waters.

YPF Sociedad Anónima (NYSE:YPF)

YPF Sociedad Anonima grew its share prices by 10.32 percent on Monday to finish at $33.13 apiece as investor sentiment was boosted by an investment bank’s rating upgrade for the firm. On Monday, HSBC raised YPF’s price target by 57 percent to $33 from $21 previously, while upgrading its rating to Hold from Reduce. The price target, however, was 0.39 percent lower than YPF’s closing price on Monday. According to HSBC, the better outlook was attributed to Argentina’s economy, energy sector, and YPF’s internal restructuring plan. In particular, HSBC said Argentina’s $20 billion loan agreement with the International Monetary Fund and the removal of foreign exchange controls have favorably impacted YPF’s funding costs, sparking investor interest in Argentine equities. YPF is a vertically integrated, state-controlled energy company engaged in oil and gas exploration, production, transportation, refining, and marketing of gas and petroleum products. Overall, YPF ranks 6th on our list of biotech stocks that dominate Monday’s top gainers. While we acknowledge the potential of YPF as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than YPF but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now  and  30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at  Insider Monkey .